Recombinant therapeutic antibodies | SpringerLink Skip to main content Advertisement
SpringerLink Log in Menu Find a journal Publish with us Search Cart 1.Home 2.Applied …

Recombinant antibody technologies are rapidly becoming available and showing
considerable clinical success. However, the immunogenicity of murine-derived monoclonal …

In this paper, a wide range of antibodies from various subclasses and subfamilies are
employed to evaluate the creation of generic separation processes using Protein A …

During biopharmaceutical process development, it is important to improve titer to reduce
drug manufacturing costs and to deliver comparable quality attributes of therapeutic …

This chapter summarizes the properties of the Protein A ligand, and reviews commercially
available Protein A resins. It discusses the development and validation of the Protein A …

Ribosome display is a polymerase chain reaction-based invitro display technology that is
well suited to the selection and evolution of high affinity antibodies. Both eukaryotic and …

Peptides are a very critical class of pharmaceutical compounds that can control several
signaling pathways and thereby affect many physiological and biochemical processes …

Expression of CD20 antigen by the most of transformed B cells is believed to be the driving
force for targeting this molecule by using anti-CD20 monoclonal antibodies. While it is true …

Today, therapeutic antibodies represent the most rapidly growing group of protein
therapeutics, and marketed products are used to treat a very diverse set of disorders …

A simple and reliable method for the detection of specific nitrogen-fixing bacteria in both free-
living and bacteroid forms is essential for the development and application of biofertilizer …